Analysis Life Sciences Thank You What We Expect the FDA to do in December 2023
Agency IQ
DECEMBER 1, 2023
12/29/2023 FDORA, Section 3202 Orphan Drug Program : FDA will convene a public meeting (or several) to solicit input from stakeholders regarding rare disease patient burdens, treatment options, side effects of treatments, etc. Within 180 days, FDA will release a report on the proceedings of the public meeting and any recommendations.
Let's personalize your content